세계의 마이크로플루이딕스 시장 보고서(2025년)
Microfluidics Global Market Report 2025
상품코드 : 1790896
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

마이크로플루이딕스 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 15.0%로 성장할 전망이며, 180억 6,000만 달러로 성장이 예측됩니다. 예측 기간의 성장은 헬스케어 업계에서 점수 관리 검사 수요가 증가하고, 마이크로플루이딕스에 대한 요구가 증가하며, 세포 기반 치료법의 임상연구수 증가 등에 기인할 것으로 예측됩니다. 예측 기간 주요 동향으로는 백혈구 분리 기술의 이용, 제품 혁신, 디지털 마이크로플루이딕스 플랫폼 채용, 마이크로플루이딕스에서의 3d 프린팅 이용, 기술 진보, invitro 진단 검사 이용, 전략적 파트너십 및 제휴 등을 들 수 있습니다.

향후 5년간의 성장률 15.0%라고 하는 예측은 전회 예측으로부터 0.2%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 타국가 간 관세의 영향 때문입니다. 이는 독일과 싱가포르의 정밀 마이크로플루이딕스 칩 비용 상승, 의료 진단 및 제약 연구소의 경비 증가를 통해 미국에 직접 영향을 미칠 것으로 보입니다. 또한 상호 관세와 무역 긴장 증가 및 제한으로 인한 세계 경제와 무역에 대한 악영향으로 그 영향이 더 광범위하게 늘어날 것으로 보입니다.

헬스케어 분야에서의 고급 포인트 오브 케어 검사(POCT)에 대한 수요 증가가 마이크로플루이딕스 시장을 견인하고 있습니다. POCT를 통해 의료 서비스 제공업체는 환자가 있는 곳이나 그 가까이에서 기존 실험실에서의 검사보다 훨씬 더 신속하게 질병을 확인하고 진단할 수 있습니다. 마이크로플루이딕스 기반 POCT 장치는 휴대가능하고 저가격이며 고정밀입니다. 세계 각국에서는 국민에게 편리한 검사 서비스를 제공하기 위해 POCT 기능에 대한 투자가 증가하고 있으며, 이러한 기기에 사용되는 혁신적인 마이크로플루이딕스 수요가 높아질 것으로 예상되고 있습니다. 예를 들어 2023년 11월 유럽연합(EU) 통계국인 유로스타트는 2022년 16세 이상의 EU 인구의 약 36.1%가 오랜 질병 및 건강 문제를 겪고 있다고 답했다고 보고했습니다. 따라서 포인트 오브 케어 검사에 대한 수요 증가는 예측 기간 동안 마이크로플루이딕스 시장의 성장을 가속할 것으로 예측됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Microfluidics is the science and technology of devices designed to process or manipulate small volumes of fluid (ranging from 10-9 to 10-18L) through channels with widths of a few tens to several hundred micrometers. Microfluidic devices are capable of performing chemical analysis on small amounts of liquid, such as droplets of blood. These devices have emerged as an alternative to conventional laboratory techniques, offering the potential to conduct complete laboratory protocols on a single small chip.

The primary types of microfluidics encompass silicone-based microfluidics, glass-based microfluidics, and polymer-based microfluidics. Silicon-based microfluidics involve the use of micro-manufactured devices for chip-scale management of tiny volumes of fluids. These devices are created by combining silicon with other materials such as glass, polymers, or other substances. Silicon-based microfluidics find applications in various fields, including industrial and environmental processes, drug delivery, pharmaceutical and life science research, analysis, and clinical and veterinary diagnostics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the metals and minerals sector, disrupting supply chains for automakers, appliance manufacturers, and infrastructure projects. With reduced competition from imports, domestic mills have increased prices, yet capacity limitations hinder their ability to fully meet demand. At the same time, mining companies are facing challenges from retaliatory tariffs on key mineral exports, especially lithium and rare earth elements. In response, industry participants are ramping up investments in scrap metal recycling, seeking tariff exemptions, and forming joint ventures with international producers to ensure a more reliable supply chain.

The microfluidics market research report is one of a series of new reports from The Business Research Company that provides microfluidics market statistics, including microfluidics industry global market size, regional shares, competitors with a microfluidics market share, detailed microfluidics market segments, market trends and opportunities, and any further data you may need to thrive in the microfluidics industry. This microfluidics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microfluidics market size has grown rapidly in recent years. It will grow from $9.16 billion in 2024 to $10.33 billion in 2025 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to strong economic growth in emerging markets, increased incidences of chronic diseases, increased number of new infections and deaths due to COVID-19 disease, and increased healthcare expenditure.

The microfluidics market size is expected to see rapid growth in the next few years. It will grow to $18.06 billion in 2029 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to rising demand for point-of-care testing in the healthcare industry, increasing need for microfluidics, and an increased number of clinical studies for cell-based therapies. Major trends in the forecast period include the use of white blood cell isolation technology, product innovations, adoption of digital microfluidics platform, use of 3d printing in microfluidics, technological advancements, use of invitro diagnostics tests, and strategic partnerships and collaborations.

The forecast of 15.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through higher costs for precision microfluidic chips from Germany and Singapore, increasing expenses for medical diagnostics and pharmaceutical research laboratories. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing demand for advanced point-of-care testing (POCT) in the healthcare sector is driving the microfluidics market. POCT enables healthcare providers to identify and diagnose illnesses quickly, often at or near the patient's location, significantly faster than traditional laboratory testing. Microfluidics-based POCT devices are portable, low-cost, and highly accurate. Countries worldwide are increasingly investing in POCT capabilities to offer convenient testing services to their populations, which is expected to enhance the demand for innovative microfluidics used in these devices. For example, in November 2023, Eurostat, the statistical office of the European Union, reported that in 2022, approximately 36.1% of the EU population aged 16 years or older indicated they had a long-standing illness or health problem. Therefore, the rising demand for point-of-care testing is anticipated to drive the growth of the microfluidics market during the forecast period.

The rise in clinical studies for cell-based therapies has significantly contributed to the growth of the microfluidics market during the historical period. Microfluidics has emerged as a promising platform for advancing biomanufacturing in drug, gene, and cell therapies by enabling enhanced synthesis of nanoscale drug and gene delivery systems, microencapsulation of drugs or cells, intracellular delivery of macromolecules, and the fabrication of macroscale constructs from micro-nano fibers. For example, in July 2023, the American Society of Gene and Cell Therapy, a US-based medical and scientific development organization, reported a 58% increase in non-oncology gene and cell therapy clinical trials in the second quarter of 2023 compared to the first quarter. Thus, the growing number of clinical studies focused on cell-based therapies is expected to drive the growth of the microfluidics market during the forecast period.

Innovation in product development is a significant contributor to the rapid growth of the microfluidics market. Companies in the microfluidics sector are actively creating innovative products to meet the escalating industry demand and enhance their market positions. For instance, Miroculus, Inc., a California-based developer of personal lab automation solutions, launched Micro Canvas in March 2022, a digital microfluidics platform designed to automate complex next-generation sequencing platforms.

Major companies in the microfluidics market are actively focused on developing innovative technological solutions to enhance their market positions. For example, in March 2024, Takara Bio, a Japan-based manufacturer of scientific reagents, launched the first commercial dissolvable microfluidic lentiviral transduction enhancer. This product employs a unique dissolvable microfluidic platform that enables precise control over the transduction process, thereby improving the delivery of lentiviral vectors into target cells. The enhancer is specifically designed to significantly boost the efficiency of lentiviral transduction, which is vital for gene therapy applications, ensuring more effective gene delivery into cells. Additionally, the microfluidic system simplifies the experimental setup, making it accessible for researchers without requiring extensive technical expertise.

In December 2022, CPS Fluidics, a US-based manufacturer of custom fluidics products, acquired Hexano Corp. for an undisclosed amount. This strategic acquisition is intended to strengthen CPS Fluidics' capabilities in the manufacturing and prototyping of microfluidic devices by leveraging Hexano's expertise and established client base. Hexano Corp. specializes in the production of microfluidic devices and is also based in the United States.

Major companies operating in the microfluidics market include Thermo Fisher Scientific, Agilent Technologies, Illumina Inc, Bio-Rad Laboratories, Fluidigm Corporation, Dolomite Microfluidics, PerkinElmer, Inc., Biosurfit SA, Sphere Fluidics Limited, Micronit Micro Technologies B.V., Parker Hannifin Corp., Fluigent, Camozzi, Gems Sensors, Inc., Aignep S.P.A., SMC Corporation, Cellix Ltd, Elveflow, Microliquid, S.L., Danaher Corporation, BD, Absolute Ozone, FlowJEM, uFluidix, QuantWave Technologies Inc., Shelron Enterprises, Harvard Bioscience, Inc., Abaxis, Inc., OPKO Health, Inc., IDEX Health & Science LLC, Stamm, The Advanced Microfluidics and Microdevices Laboratory, Chromatotec Group, Abbott, Safarmex PTY Ltd

North America was the largest region in the microfluidics market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the microfluidics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the microfluidics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, and Canada.

The microfluidics market includes revenues earned by entities by developing molecular sensors based on bioassays, such as DNA amplification and analysis, cell separation, and immunoassay, among many more examples. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Microfluidics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on microfluidics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for microfluidics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The microfluidics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Microfluidics Market Characteristics

3. Microfluidics Market Trends And Strategies

4. Microfluidics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Microfluidics Growth Analysis And Strategic Analysis Framework

6. Microfluidics Market Segmentation

7. Microfluidics Market Regional And Country Analysis

8. Asia-Pacific Microfluidics Market

9. China Microfluidics Market

10. India Microfluidics Market

11. Japan Microfluidics Market

12. Australia Microfluidics Market

13. Indonesia Microfluidics Market

14. South Korea Microfluidics Market

15. Western Europe Microfluidics Market

16. UK Microfluidics Market

17. Germany Microfluidics Market

18. France Microfluidics Market

19. Italy Microfluidics Market

20. Spain Microfluidics Market

21. Eastern Europe Microfluidics Market

22. Russia Microfluidics Market

23. North America Microfluidics Market

24. USA Microfluidics Market

25. Canada Microfluidics Market

26. South America Microfluidics Market

27. Brazil Microfluidics Market

28. Middle East Microfluidics Market

29. Africa Microfluidics Market

30. Microfluidics Market Competitive Landscape And Company Profiles

31. Microfluidics Market Other Major And Innovative Companies

32. Global Microfluidics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Microfluidics Market

34. Recent Developments In The Microfluidics Market

35. Microfluidics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기